Phone: 86-29-89601602
Mail: sales27@interlgroup.com
Add: Room 305 , 3/F , Haipai Decoration Office Building , Yudu Avenue , Yuncheng , Shanxi
Clobetasol propionate powder Raw Materials CAS 25122-46-7
Product Overview:
Clobetasol propionate is a dermatological medication. Topical use is suitable for chronic eczema, neurodermatitis, psoriasis, palmoplantar impetigo, lichen planus, discoid lupus erythematosus and other effective topical use of glucocorticoids for pruritus and non-infectious inflammatory skin diseases. Clobetasol propionate powder has a rapid action and is one of the most potent topical corticosteroids currently in clinical use. The anti-inflammatory effect of Clobetasol propionate is 112.5 times that of hydrocortisone, 2.3 times that of betamethasone sodium phosphate and 18.7 times that of fluoconide. The systemic adverse reactions were 3 times that of fluoxonide, anhydrous sodium retention, and had a certain effect of promoting sodium and potassium excretion.
Clobetasol propionate powder Raw Materials CAS 25122-46-7 Attributes
Product name:Clobetasol propionate powder
CAS:25122-46-7
MF:C25H32ClFO5
MW:466.97
EINECS:246-634-3
Specification:Clobetasol propionate powder
Sample:Clobetasol propionate powder Avaliable
Appearance:white powder
Storage: Cool Dry Place
Brand:Global ASAP Nutrition Factory
Shelf Life: 2 Years
Test Method: HPLC
Clobetasol propionate powder Raw Materials CAS 25122-46-7 Details
Uses and synthesis of Clobetasol propionate powder
Clobetasol propionate is a dermatological medication. Topical use is suitable for chronic eczema, neurodermatitis, psoriasis, palmoplantar impetigo, lichen planus, discoid lupus erythematosus and other effective topical use of glucocorticoids for pruritus and non-infectious inflammatory skin diseases. Clobetasol propionate powder has a rapid action and is one of the most potent topical corticosteroids currently in clinical use. The anti-inflammatory effect of Clobetasol propionate is 112.5 times that of hydrocortisone, 2.3 times that of betamethasone sodium phosphate and 18.7 times that of fluoconide. The systemic adverse reactions were 3 times that of fluoxonide, anhydrous sodium retention, and had a certain effect of promoting sodium and potassium excretion.
Functions of Clobetasol propionate powder.
Psoriasis: Especially plaque psoriasis, relieves redness, scaling, and itching.Eczema/Atopic Dermatitis: Treats severe eczema attacks, relieves itching, redness, and oozing.
Lichen Planus: Relieves itchy rashes on the skin and mucous membranes.
Discoid Lupus Erythematosus: Treats the cutaneous form of lupus erythematosus.
Neurodermatitis: Treats thickening and lichenification of the skin caused by chronic itching and friction.
Pustulosis Palmaris et Plantaris: Relieves pustules and inflammation on the palms and soles of the feet
Mechanism of action of Clobetasol propionate powder.
Inhibit the release of inflammatory mediators: Reduce the release of chemicals (inflammatory mediators) such as prostaglandins, leukotrienes and cytokines released by inflammatory cells (such as white blood cells), which are the key to causing inflammatory reactions such as redness, swelling, heat and pain.
Inhibit immune response: Inhibit the overactivity of the local immune system, reduce the infiltration of immune cells and inflammatory response.
Vascular constriction: Constrict blood vessels, reduce blood flow to the site of inflammation, and thus reduce redness and swelling.
Inhibit cell proliferation: Reduce the excessive proliferation of skin cells, which helps treat diseases such as psoriasis characterized by excessive proliferation of skin cells.
Drug interactions of Clobetasol propionate powder.
The systemic absorption of topical clobetasol propionate is usually low, so the possibility of clinically significant interactions with other drugs is low. However, in theory, if it is used over a large area for a long time, or an occlusive dressing is used to increase systemic absorption, it may interact with strong CYP3A4 enzyme inhibitors (such as ketoconazole, itraconazole, ritonavir, etc.), increasing the systemic exposure of clobetasol propionate and the risk of side effects.


